Diabetes type1
Metabolic Diseases
2
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program1
Semaglutide Pen InjectorPhase 2Peptide1 trial
Active Trials
Alliance PharmaceuticalsUK - Wiltshire
1 programDevice: Actiste 1.0 and the Companion app with TBL BackendN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Novo NordiskSemaglutide Pen Injector
PrecigenAG019 - Low Dose
Alliance PharmaceuticalsDevice: Actiste 1.0 and the Companion app with TBL Backend
Clinical Trials (3)
Total enrollment: 112 patients across 3 trials
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
Start: Jul 2024Est. completion: Jun 202854 patients
Phase 2Recruiting
A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)
Start: Oct 2018Est. completion: Oct 202145 patients
Phase 1/2Completed
Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation
Start: Mar 2022Est. completion: Dec 202213 patients
N/ACompleted
Related Jobs in Metabolic Diseases
Manager, Patient Safety and Pharmacovigilance Operations
Kailera Therapeutics
Waltham, Massachusetts
9h ago
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
Yesterday
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Application & Integration Architect
Roche
Indianapolis
5d ago
$106K - $196K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 112 patients
3 companies competing in this space